Pythium insidiosum causes life-threatening human pythiosis. Based on phylogenetic analysis using internal transcribed spacer (ITS) region, mitochondrial cytochrome C oxidase II (COX2) gene, intergenic spacer (IGS) region and exo-1,3-β-glucanase gene (exo1), P. insidiosum is classified into clade A TH , B TH , and C TH related to geographic distribution. At present, polymerase chain reaction in any of these specific regions with DNA sequencing is the only technique to provide clade diagnosis. In this study, P. insidiosum-specific primers targeting COX2 gene were designed and used in real-time quantitative polymerase chain reaction (qPCR) with subsequent high-resolution melting (HRM) to provide rapid identification as well as clade classification for P. insidiosum. Based on the qPCR-HRM method, 15 P. insidiosum isolates could be differentiated from 28 related organisms with 100% specificity and 1 pg limit of detection. This technique was, in addition, directly tested on clinical samples from proved human pythiosis cases: nine corneal scrapes and six arterial clots. The qPCR-HRM results of all nine corneal samples were a 100% match with the results from the conventional PCR at clade level. However, the qPCR-HRM results of arterial clot samples were only matched with the nucleotide sequencing results from the conventional PCR at species level. In conclusion, the qPCR-HRM is a simple one closed tube, inexpensive and user-friendly method to identify P. insidiosum into clade level.
Introduction
Pythium insidiosum, is an aquatic oomycete fungus-like organism, which causes pythiosis in humans, mammals, and birds. 1 This organism is widely found in its natural habitat, specifically agricultural swamp areas and stagnant fresh water. It is known as a soil borne saprophyte as well as a plant pathogen throughout the world. 2, 3 Recently, this organism was ubiquitously found in urban and suburban lakes in North Central Florida, USA, and this was probably the first report of natural habitat in the United States. 4 P. insidiosum is classified into 3 clades: clade I, II, and III based on phylogenetic tree analysis using internal transcribed spacer (ITS) region or intergenic spacer (IGS) region or exo-1,3-β-glucanase gene (exo1) or clade A TH , B TH , C TH by using mitochondrial cytochrome C oxidase II (COX2). Clade A TH or clade I is mostly found in American continent; Clade B TH or clade II is usually found in Asia and Australia; Clade C TH or clade III is found in Thailand and the United States. [5] [6] [7] [8] With regards to human diseases, the majority of the cases have been reported from Thailand. 9, 10 Human pythiosis is classified into four groups based on clinical presentations: cutaneous/subcutaneous, ocular, vascular, and disseminated disease. 9, 10 The combination of aggressive surgery, antifungal agents, and immunotherapy has been used as salvage treatment in several institutions; however, the effective treatment has not yet been established. It is known that surgery with adequate surgical margins is the main factor for patients' survival in vascular disease regardless of antifungal agents or immunotherapy administration. 10 Given this reason, early diagnosis and treatment is a very crucial determinant to decrease morbidity and mortality. The inefficacy of immunotherapy in the previous series was thought to be due to administration of immunotherapy from a discordant pathogen clade. 11 Currently, immunotherapy is only available for P. insidiosum A TH ; however, none of the Thai patients were infected with clade A TH . Chindamporn et al. found that serum antibodies from P. insidiosum infected patients recognized various immunogens in geographically divergent P. insidiosum strains by Western blot, but dominant antigen-antibody reactions were observed in the same pathogen clade. 11 This implied the efficacy of immunotherapy may require antigens belonging to the same clade of the pathogens. Presently, at least two diagnostic methods including histopathological staining, culture, serology, and polymerase chain reaction (conventional PCR) with DNA sequencing are required to provide definitive diagnosis for human pythiosis in patients with compatible clinical contexts. 2, 10 At our medical center, the PCR with DNA sequencing by ITS region and COX2 gene have been used for clade differentiation. The phylogenetic tree using COX2 gene has showed higher discriminatory power than using ITS for sister-group classification. 5, 7 The alignment of P. insidiosum's partial COX2 nucleic acid sequences presented the clade specific single-nucleotide polymorphisms (SNPs). These mutations are significant points particularly for clade disclosure. In addition to DNA sequencing, real-time quantitative polymerase chain reaction (qPCR) with subsequent High Resolution Melting (HRM) is another method to detect the SNPs. 12 The qPCR can amplify nucleotide at the specific target of interest. The SNPs in amplicons, covered by designed primers, are used for the following HRM analysis steps. By theory, HRM is one of high sensitivity assays to detect the different melting temperature (Tm) caused by A/T or C/G bonding in each SNP pattern. Thus, the SNPs can be detected accurately without sequencing process.
In the past few years, this novel technique has been investigated, and it has been successfully applied for diagnostic purposes in various research areas including detection and analysis of cancer-related mutations in humans, identification and genotyping of parasites, bacteria, and fungi. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Despite its wide use in clinical medicine and agriculture, this technique has not been studied for P. insidiosum identification yet. In this study, the qPCR-HRM technique was developed for P. insidiosum identification as well as clade differentiation from clinical and environmental isolates.
Methods
The study protocol was approved by the Chulalongkorn University Institutional Review Board based on the international guidelines for human research protection in- 
Organisms and clinical specimens
A total of 58 samples were tested in this study. Fortythree isolates of P. insidiosum (n = 15), Pythium spp. (n = 2), pathogens with similar morphology in kingdom Stramenopila (n = 3) and kingdom Fungi (n = 23) ( Table  1) , and 15 clinical specimens from proved human pythiosis, nine corneal scrapes and six arterial clots, were included in this study ( Table 2 ). All isolates' genus and species were proved by the conventional PCR with sequencing of ITS region and/or COX2 gene. Similar to those isolates, all recruited specimens with P. insidiosum infection were proved by positive conventional PCR with sequencing of ITS region and COX2 gene directly from specimens and/or positive culture. Sera from all patients, whose arterial clots were collected for this study, were tested for specific P. insidiosum antibody by in-house enzyme-linked immunosorbent assay (ELISA). Traditionally, P. insidiosum and other related fungi were differentiated by growth rate, presence of sterile hyphae, zoospore production, P. insidiosum specific antibody detection by ELISA, and conventional PCR with DNA sequencing technique. These methods were used as control in this study.
DNA preparation
The genomic DNAs (gDNAs) of all tested isolates were prepared by QIAamp DNA Mini kit (Cat. 51306, QIAGEN, Germantown, MD, USA). In brief, isolates were lysed by 180 μl ATL buffer and 20 μl proteinase K at 56
Then, protein denaturation step was performed by 200 μl AL buffer. After centrifugation, the upper part was purified and precipitated with 200 μl absolute ethanol. The mixer was filtered through the QIAamp Mini Spin column and washed again by 500 μl AW1 and AW2 buffer. Finally, a ratio of 1.8 to 2.0, based on A 260 /A 280 ratio by NanoDrop (NanoDrop TM 1000 Spectrophotometer Thermo scientific, Skokie, IL, USA), was used to determine DNA quality and quantity.
Real-time quantitative polymerase chain reaction (qPCR) and post-HRM analysis
The qPCR amplification of 91 bp in COX2 gene was performed by the newly designed primers: Cox Pi 5 (5'-TAA TTT GGA CTA CTA TTC CAG C-3') and Cox Pi 6 (5'-GGA TCA ATG TAT TTC ATC CAT AG-3') ( Fig. 1 In every run, these templates were used as reference curves. The melt curve genotyping was plotted based on melting temperatures of the amplicons. Regarding post-HRM genotyping analysis, the amplification products were denatured at 95
• C for 1 min and were cooled at 40
• C for 1 min to complete double-stranded amplicons. The HRM melting curves were generated by ramping from 65 to 90
• C, and the curves were monitored fluorescence at the rate These curves were plotted by using the automated grouping option in the program (Fig. 2B and C) . More than 95% confidence of similarity compared to reference gDNA templates by HRM analysis was accepted for clade classification ( Fig. 2A) . To evaluate the limit of detection (LOD) of qPCR and post-HRM, 1 pg to 10 ng of gDNA were tested. The gDNA of all isolates were tested in triplicate blinded experiments. The gDNA of Staphylococcus spp., human and molecular grade water were used as negative controls. The specificity test was challenged by using other fungal gDNAs (n = 28) as follows: The cut-off for the same clade was more than 95% confidence of similarity calculated by HRM analysis. Finally, the results of the qPCR-HRM analysis of the tested isolates were compared to the sequences of ITS region and COX2 gene which was the standard method in this study.
The qPCR-HRM for clinical samples
To shorten the processes and avoid complicated gDNA extraction steps, we applied this qPCR-HRM analysis directly to clinical specimens, arterial clots, and corneal scrapes. All clinical specimens were cut into small pieces (approximately 1 mm × 1 mm in length and width) and directly mixed in the qPCR reactions (Table 2 ). This mixture was processed by the qPCR-HRM as same as the fungal isolates described in previous section. The additional DNA extraction was required in arterial clot samples to improve the efficiency of the qPCR-HRM. Their gDNA were prepared by QIAamp DNA Mini kit (Cat. 51306, QIAGEN, USA) prior to being used as templates in the qPCR-HRM reactions.
Results

The qPCR-HRM results: fungal isolates
Twenty-two out of 43 tested isolates could be amplified by COX2 specific primers (Table 1) with C p value between cycles 14 and 18 (cycles 16 in average) in the qPCR process. Twenty isolates were from phylum Oomycota, and two isolates were from order Entomophthorales, phylum Glomeromycota (former Zygomycota). 23 No PCR products were detected from the negative controls. Based on the melt curve genotyping, there were no significant differences in melting temperatures (Tm) among those 22 amplifiable isolates. (Fig. 2A) . The three clades achieved from HRM analysis were correlated with the clustering based on DNA sequences. The non-A TH B TH C TH pattern was produced from seven out of 22 amplifiable isolates, and this pattern did not meet the criteria of ≥95% confidence of similarity. This result indicated that these seven isolates were not P. insidiosum, correlated with the identification results by conventional PCR with DNA sequencing. The non-A TH B TH C TH pattern was generated by P. aphanidermatum, P. catenulatum, Phy. parasitica, Phy. sojae, Lagenidium albertoi, Basidiobolus meristosporus, and Conidiobolus coronatus.
The qPCR-HRM results: clinical specimens
A total of nine corneal scrapes and six arterial clots were examined (Table 2) . Only 11/15 clinical samples, nine corneal tissues, and two arterial clots were amplified. None of them met the criteria of ≥95% confidence of similarity compared to reference P. insidiosum isolates. All samples from corneal scrapes showed ≥85% confidence of similarity; Cp 16.27 ± 0.68. Two clades were identified: clade B TH (5/9 samples, 87.2-89.4% confidence of similarity) and clade C TH (4/9 samples, 85.1-89.0% confidence of similarity). None of arterial clots can be classified into clade level without an additional gDNA extraction. However, with the additional gDNA extraction from the specimens, all 6 arterial clots were successfully amplified and can be classified into clade level by qPCR-HRM with Cp of 16.39 ± 0.8.
Specificity and limit of detection
The specificity of the qPCR-HRM was evaluated by using other fungal gDNAs as templates for qPCR-HRM reactions under the same condition as P. indiosum's gDNA. There were no false positive or false negative results. These results revealed 100% specificity of the qPCR-HRM. With regards to the limit of detection, different concentrations of P. insidiosum's gDNA ranging from 1 pg to 10 ng were examined. One picogram of gDNA was the lowest detectable amount by this qPCR-HRM.
Reproducibility of the qPCR-HRM
The reproducibility and consistency of qPCR-HRM protocols were evaluated by running HRM in triplicate from six random isolates: three from clade B TH and three from clade C TH . Since there was the only one isolate for clade A TH , the reproducibility and consistency of these protocols were tested by extracting gDNA in triplicate from three different subcultures of the isolate. The HRM analysis was performed in each lot of gDNA preparation. Our protocols were found to have very high consistency and reproducibility (Table 1) . Among the control reactions, very small variation with Cp of 15.4 ± 0.4 was observed.
Discussion
In this study, the qPCR-HRM analysis was first developed to provide rapid clade specific diagnosis for patients with pythiosis. The results from conventional PCR with DNA sequencing for clade identification were similar to the results from the qPCR-HRM. Several advantages of the qPCR-HRM are as follows; first, P. insidiosum can be differentiated from other true fungi and be classified into the clade level with turnaround time of four hours while at least 18 hours are required for conventional approach. Second, this technique was first implemented to identify P. insidiosum directly clinical samples, and it was successful for corneal scrapes. Third, the qPCR-HRM is convenient because only one closed tube system is required and this will significantly reduce risk of contamination during multistep processes of conventional PCR. Lastly, the qPCR-HRM is approximately 5 times cheaper than the conventional PCR with DNA sequencing, and this technology will be widely accessible especially among developing countries. Several techniques for P. insidiosum identification such as thermophilic helicase DNA amplification with restriction fragment length polymorphism (tHDA-RFLP) targeting COX2 gene, 23 real-time PCR targeting exo-1,3-betaglucanase gene (PinsEXO1), 245 and screening method based on the growth of P. insidiosum mycelia around minocycline disks (30 μg) 25 have been reported. All identification methods have mainly used gDNA template from cultures or non-clinical specimens; however, they are only able to provide diagnosis into the species level [23] [24] [25] . In this study, both species and clade diagnosis can be obtained by nonsequencing based qPCR-HRM with 100% specificity. All the clade classification results from 15 P. insidiosum gDNA template tested samples obtained from both conventional PCR-sequencing and the new qPCR-HRM methods are 100% match. The confidence percentage of similarity results from our qPCR-HRM for clade identification are as high as the previous reported results in the literature for species identification in other organisms. 14, [26] [27] [28] This indicates that our developed assay is highly accurate and applicable for P. insidiosum identification. Direct amplification from clinical specimens is the ultimate goal. The main advantage of amplification directly from clinical specimens is to increase detection yield of P. insidiosum in case of cultivation failure. The intolerance to low temperature of P. insidiosum during transportation and sample preparation is a major barrier causing false negative results in real-world practice. 29 In this study, we successfully identified P. insidiosum from all corneal scrapes samples corresponding to the DNA sequence base assay. Ocular pythiosis can be diagnosed within a working day by the qPCR-HRM, but it is almost impossible by conventional PCR with DNA sequencing and standard cultivation method. In case of arterial clots, low success rate was observed by the qPCR-HRM. We hypothesize that clot samples may not have been completely lysed by typical denatured temperature, and it led to impurity of DNA extracts. 30 To prove this hypothesis, we extracted the gDNA from these samples and processed the qPCR-HRM. As expected, all six arterial clots were amplified and P. insidiosum was identified. Although a few extra hours were required for DNA extraction from arterial clots, the qPCR-HRM could still be considered as a rapid diagnosis compared to the conventional PCR with DNA sequencing. In terms of clade classification by directly using clinical specimens, all of the results were 100% match to the nucleotide sequence assay, even though only 85.1-89.4% similarity by HRM were achieved from the corneal scrapes. The lower percentage of similarity in clinical specimens was probably due to unpurified samples, inhibitors in DNA extracts, or different concentrations of magnesium salt. 32 To increase higher percentage of similarity for the qPCR-HRM, additional steps may be required. These steps are pre-amplification step (gDNA extraction and purification) and pre-HRM analysis step (PCR purification). 31 However, we decided not to pursue the additional DNA extraction and purification because we had limited specimens and DNA would be lost during these processes.
In conclusion, this new qPCR-HRM technique is a novel tool for conclusive P. insidiosum identification and clade classification. Owing to the rapid, user-friendly, and inexpensive process, this technique is another option to help improve patient care by facilitating early diagnosis and guiding appropriate immunotherapy in the future. With clade identification, we also hope this technique will provide more epidemiologic data in different geographic areas.
